No PPI Required for EGJOO Without Reflux Symptoms
She does not need a PPI. In the absence of reflux symptoms (heartburn, regurgitation) and without documented gastroesophageal reflux disease, there is no indication for proton pump inhibitor therapy in functional EGJOO 1.
Rationale Based on Guidelines
The 2022 AGA guidelines on PPI de-prescribing explicitly list appropriate indications for PPI therapy, and EGJOO is not among them 1. The conditions warranting PPI use include:
- Documented GERD with erosive esophagitis (especially LA grade C/D)
- Barrett's esophagus
- Eosinophilic esophagitis (when PPI-responsive)
- Gastroprotection in high-risk NSAID/aspirin users
- Documented peptic ulcer disease
The British Society of Gastroenterology guidelines further clarify that PPIs should only be prescribed when there are actual reflux symptoms (heartburn, acid regurgitation, or chest pain attributed to reflux) 2. A therapeutic trial consists of twice-daily full-dose PPI for 4 weeks, considered positive only if there is ≥75% reduction in symptom frequency 2.
Understanding EGJOO Context
EGJOO is a manometric finding characterized by impaired esophagogastric junction relaxation with preserved peristalsis 3, 4. It can be:
- Artifactual (catheter positioning)
- Secondary (mechanical obstruction, medications)
- Functional (true motility disorder, rarely progressing to achalasia)
Most functional EGJOO cases are self-limiting and do not require intervention 5, 6. The primary symptoms are dysphagia and chest pain—not reflux 3.
Key Clinical Pitfalls to Avoid
Do not reflexively prescribe PPIs for esophageal motility disorders. The mechanism of EGJOO involves impaired LES relaxation, not excessive acid exposure. PPIs:
- Will not improve dysphagia from outflow obstruction
- Have no role in treating the underlying motility abnormality
- Expose patients to unnecessary medication risks when used without indication 1
When to Reconsider
PPI therapy would only be appropriate if she develops:
- New reflux symptoms (heartburn, regurgitation occurring ≥2 times weekly)
- Documented erosive esophagitis on endoscopy
- Barrett's esophagus (requires indefinite PPI therapy) 1
If reflux symptoms emerge, confirm with pH/impedance monitoring off PPIs before committing to long-term therapy 2.
Management Focus for EGJOO
Instead of PPIs, management should focus on:
- Confirming clinical relevance with timed barium esophagram or FLIP if dysphagia is significant 3, 4
- Excluding mechanical obstruction with endoscopy and cross-sectional imaging
- Conservative observation for most cases (87% of non-obese patients have symptom resolution) 5
- LES-directed therapy (pneumatic dilation, POEM) only if confirmed functional obstruction with persistent dysphagia 3, 6